Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors

Virology

Volumn 321, Issue 2, 2004, Pages 287-296

  Gonçalves, Manuel A F V ^a   Van Der Velde, Ietje ^a   Knaän Shanzer, Shoshan ^a   Valerio, Dinko ^a   De Vries, Antoine A F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adeno associated virus; Adenovirus; Genomic integration; Hybrid vector; Long term gene expression

Indexed keywords

ADENOVIRUS VECTOR; GENOMIC DNA; VIRUS DNA;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA TRANSFER; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HYBRID GENE; INVERTED TERMINAL REPEAT; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; CAPSID; DEPENDOVIRUS; DNA, VIRAL; GENE EXPRESSION; GENETIC VECTORS; HELA CELLS; HUMANS; RECOMBINATION, GENETIC; TERMINAL REPEAT SEQUENCES; TRANSDUCTION, GENETIC; VIRUS INTEGRATION;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; MIRIDAE;

EID: 1642446588     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.01.007     Document Type: Article

References (32)

1. Aiuti A., Slavin S., Aker M., Ficara F., Deola S., Mortellaro A., Morecki S., Andolfi G., Tabucchi A., Carlucci F., Marinello E., Cattaneo F., Vai S., Servida P., Miniero R., Roncarolo M.G., Bordignon C. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science. 296:2002;2410-2413.
2. Attal J., Théron M.-C., Kann G., Bolifraud P., Puissant C., Houdebine L.M. The stimulation of gene expression by the R region from HTLV-1 and BLV. J. Biotechnol. 77:2000;179-189.
3. Chen W.Y., Bailey E.C., McCune S.L., Dong J.-Y., Townes T.M. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;5798-5803.
4. Detrait E.R., Bowers W.J., Halterman M.W., Giuliano R.E., Bennice L., Federoff H.J., Richfield E.K. Reporter gene transfer induces apoptosis in primary cortical neurons. Mol. Ther. 5:2002;723-730.
5. Felts K., Rogers B., Chen K., Ji H., Sorge J., Vaillancourt P. Recombinant Renilla reniformis GFP displays low toxicity. Strateg. Newsl.-Stratagene. 13:2000;85-87.
6. Gonçalves M.A.F.V., Pau M.G., de Vries A.A.F., Valerio D. Generation of a high-capacity hybrid vector: Packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. Virology. 288:2001;236-246.
7. Gonçalves M.A.F.V., van der Velde I., Janssen J.M., Maassen B.T.H., Heemskerk E.H., Opstelten D.-J.E., Knaän-Shanzer S., Valerio D., de Vries A.A.F. Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors. J. Virol. 76:2002;10734-10744.
8. Gottlieb J., Muzyczka N. In vitro excision of adeno-associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences. Mol. Cell. Biol. 8:1988;2513-2522.
9. Gottlieb J., Muzyczka N. Substrate specificity of HeLa endonuclease R. A G-specific mammalian endonuclease. J. Biol. Chem. 265:1990;10842-10850.
10. Hacein-Bey-Abina S., Le Deist F., Carlier F., Bouneaud C., Hue C., De Villartay J.-P., Thrasher A.J., Wulffraat N., Sorensen R., Dupuis-Girod S., Fisher A., Davies E.G., Kuis W., Leiva L., Cavazzana-Calvo M. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346:2002;1185-1193.
11. Hanazono Y., Yu J.-M., Dunbar C.E., Emmons R.V.B. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hum. Gene Ther. 8:1997;1313-1319.
12. Harui A., Suzuki S., Kochanek S., Mitani K. Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73:1999;6141-6146.
13. Hitt M.M., Parks R.J., Graham F.L. Structure and genetic organization of adenovirus vectors. Friedmann T. The Development of Human Gene Therapy. 1999;61-86 Cold Spring Harbor Laboratory Press, New York.
14. Knaän-Shanzer S., van der Velde I., Havenga M.J.E., Lemckert A.A.C., de Vries A.A.F., Valerio D. Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B. Hum. Gene Ther. 12:2001;1989-2005.
15. Kochanek S., Schiedner G., Volpers C. High-capacity "gutless" adenoviral vectors. Curr. Opin. Mol. Ther. 3:2001;454-463.
16. Liu H.-S., Jan M.-S., Chou C.-K., Chen P.-H., Ke N.-J. Is green fluorescence protein toxic to the living cells? Biochem. Biophys. Res. Commun. 260:1999;712-717.
17. McLaughlin S.K., Collis P., Hermonat P.L., Muzyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62:1988;1963-1973.
18. Miller D.G., Rutledge E.A., Russell D.W. Chromosomal effects of adeno-associated virus vector integration. Nat. Genet. 30:2002;147-148.
19. Mitani K., Kubo S. Adenovirus as an integrating vector. Curr. Gene Ther. 2:2002;135-144.
20. Nakai H., Iwaki Y., Kay M.A., Couto L.B. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 73:1999;5438-5447.
21. Nakai H., Montini E., Fuess S., Storm T.A., Grompe M., Kay M.A. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34:2003;297-302.
22. Nakai H., Montini E., Fuess S., Storm T.A., Meuse L., Finegold M., Grompe M., Kay M.A. Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice. Mol. Ther. 7:2003;101-111.
23. Nony P., Tessier J., Chadeuf G., Ward P., Giraud A., Dugast M., Linden R.M., Moullier P., Salvetti A. Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. J. Virol. 75:2001;9991-9994.
24. Orkin S.H., Motulsky A.G. Report and Recommendations of the Panel to Access the NIH Investment in Research on Gene Therapy. 1995;National Institutes of Health, Bethesda.
25. Philpott N.J., Giraud-Wali C., Dupuis C., Gomos J., Hamilton H., Berns K.I., Falck-Pedersen E. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. J. Virol. 76:2002;5411-5421.
26. Russell D.W., Alexander I.E., Miller A.D. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5719-5723.
27. Rutledge E.A., Russell D.W. Adeno-associated virus vector integration junctions. J. Virol. 71:1997;8429-8436.
28. Samulski R.J., Sally M., Muzyczka N. Adeno-associated viral vectors. Friedmann T. The Development of Human Gene Therapy. 1999;131-172 Cold Spring Harbor Laboratory Press, New York.
29. Tullis G.E., Shenk T. Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size. J. Virol. 74:2000;11511-11521.
30. Ward P., Berns K.I. In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome. J. Mol. Biol. 218:1991;791-804.
31. Xiao X., Xiao W., Li J., Samulski R.J. A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J. Virol. 71:1997;941-948.
32. Yang C.C., Xiao X., Zhu X., Ansardi D.C., Epstein N.D., Frey M.R., Matera A.G., Samulski R.J. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71:1997;9231-9247.